MRK vs BDX
By Alex · Tickerpine
Merck & Co., Inc. vs Becton, Dickinson and Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | BDX |
|---|---|---|
| Price | $145.27 | $198.91 |
| Market cap | $358.41B | $54.18B |
| P/E ratio | 117.2 | 46.3 |
| ROE | 6.96% | 6.61% |
| Profit margin | 4.77% | 4.19% |
| Revenue growth | 5.10% | 5.40% |
| Dividend yield | 2.34% | 2.11% |
| Beta | 0.22 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs BDX in plain English
- MRK is the bigger company — about 6.6× the market cap of BDX.
- BDX is cheaper on earnings (P/E 46.3 vs 117.2).
- MRK earns a higher return on equity (7% vs 7%).
- BDX is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.34% vs 2.11%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
BDX return calculator
See what $1,000 in Becton, Dickinson and Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.